title: UFT-induced haemolytic anaemia.
abstract: A case of haemolytic anaemia in a patient under treatment with UFT for metastatic colon cancer is reported. Haemolytic anaemia has previously been associated with many other chemotherapeutic agents, but not with UFT, an oral anticancer agent combining tegafur (Ftorafur, a prodrug of 5-fluorouracil) and uracil.
authors.forename: A J
authors.initials: AJ
authors.lastname: Zurita Saavedra
authors.forename: M
authors.initials: M
authors.lastname: Navarro Garcia
authors.forename: I
authors.initials: I
authors.lastname: Español
authors.forename: A
authors.initials: A
authors.lastname: Fernández Ortega
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003110:Colonic Neoplasms / Q000188:drug therapy; D006801:Humans; D008297:Male; D005641:Tegafur / Q000009:adverse effects*; D014498:Uracil / Q000009:adverse effects*
chemical_list: D005641:Tegafur; D014498:Uracil